Health
Johnson & Johnson COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies – manilastandard.net
Johnson Johnson announced that its lead vaccine candidate for COVID-19 elicited a robust immune response as demonstrated by neutralizing antibodies in pre-clinical studies.
6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines
Trunklines: 832-5554, 832-5556, 832-5558…
Continue Reading
